Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

  • There is currently no data for BMK

Breeding & Genetics Contract Win

12 Jul 2016 07:00

RNS Number : 8661D
Benchmark Holdings PLC
12 July 2016
 

RNS Reach

 

Benchmark Holdings plc("Benchmark" or the "Company")

 

Contract win for Breeding & Genetics division

 

Benchmark Holdings announces that a subsidiary of its Breeding & Genetics division SalmoBreed AS ("SalmoBreed") has signed a ten-year agreement with Lerøy Aakvik Roe and Stamfisk AS ("Lerøy") - one of the world's top three salmon producers - for the supply of the SalmoBreed genetic stem into its production sites. The agreement will see the Lerøy team start breeding with SalmoBreed's genetic lines, producing SalmoBreed strain ova for sale to companies within the Lerøy Group.

 

The agreement will not make a material financial contribution to Benchmark in the short term, however the Directors believe that it is of strategic importance to Benchmark's position in the market. This contract represents an endorsement of SalmoBreed's ability to produce world-class salmon strains, and is an encouraging collaboration with one of the largest producers in the industry.

 

Benchmark's CEO, Malcolm Pye, commented:

 

"We are very pleased to have reached this agreement with such a prominent player in the space, which is testament to the great work being done at SalmoBreed and in our Breeding & Genetics division as a whole. The opportunity to collaborate with Lerøy and have SalmoBreed's genetic lines distributed to its Group establishes SalmoBreed's position as an industry leader."

 

 

-ENDS-

 

Benchmark Holdings plc

Tel: +44 (0)1142 409939

Malcolm Pye, CEO

Roland Bonney, COO

Rachel Aninakwah, Communications

Tel: +44 (0)1865 790880

 

Numis

 

Tel: +44 (0)2072 601000

Michael Meade/Freddie Barnfield (NOMAD)

James Black / Tom Ballard (Corporate Broking)

Tavistock

Tel: +44 (0)2079 203150

Matt Ridsdale/Niall Walsh

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRARBMFTMBBBBTF
Date   Source Headline
2nd Jul 20187:00 amRNSAppointment of Executive Director
29th Jun 20187:00 amRNSTotal Voting Rights
27th Jun 20184:36 pmRNSHolding(s) in Company
25th Jun 20184:01 pmRNSHolding(s) in Company
22nd Jun 20184:31 pmRNSHolding(s) in Company
22nd Jun 20187:00 amRNSDIRECTOR DEALINGS
19th Jun 20184:06 pmRNSUpdate on Joint Venture and Placing
19th Jun 20187:00 amRNSInterim Results
8th Jun 20187:00 amRNSJoint Venture, Placing and Trading Update
31st May 20187:00 amRNSTotal Voting Rights
8th May 20187:00 amRNSAppointment of Chairman
30th Apr 201812:23 pmRNSTotal Voting Rights
9th Apr 201811:14 amRNSHolding(s) in Company
5th Apr 20183:58 pmRNSHolding(s) in Company
3rd Apr 20187:00 amRNSTotal Voting Rights
27th Mar 20187:00 amRNSBenchmark hosts Capital Markets Day today
21st Mar 20187:00 amRNSBlock listing six monthly return
8th Mar 20181:37 pmRNSResult of AGM
7th Feb 20189:05 amRNSDirector Dealings
31st Jan 20187:00 amRNSBoard Succession
31st Jan 20187:00 amRNSTotal Voting Rights
25th Jan 201811:54 amRNSDirector Share Options
24th Jan 20183:17 pmRNSHolding(s) in Company
24th Jan 20181:01 pmRNSDirector Dealings
24th Jan 20187:00 amRNSPosting of Annual Report & Notice of AGM
23rd Jan 20187:08 amRNSFinal Results
19th Jan 20184:40 pmRNSSecond Price Monitoring Extn
19th Jan 20184:35 pmRNSPrice Monitoring Extension
5th Jan 20184:19 pmRNSHolding(s) in Company
4th Jan 20184:41 pmRNSSecond Price Monitoring Extn
4th Jan 20184:35 pmRNSPrice Monitoring Extension
12th Dec 20177:00 amRNSCommercial scale field trial of sea lice treatment
7th Dec 20177:00 amRNSBenchmark participates in gene editing research
5th Dec 20177:00 amRNSTrading Update and Notice of Results
8th Nov 20177:00 amRNSDevelopment of disease-resistant shrimp
6th Nov 201712:20 pmRNSReplacement: Directorate Change
6th Nov 20177:00 amRNSDirectorate Change
30th Oct 20177:00 amRNSLand-based Broodstock Facility Reaches Milestone
17th Oct 20177:00 amRNSNew Vaccine Facility Delivers First Production
10th Oct 20172:41 pmRNSHolding(s) in Company
21st Sep 20177:00 amRNSBlock Listing Six Monthly Return
8th Sep 20177:00 amRNSTrading Update
22nd Aug 20177:00 amRNSRenewal of Sales and Marketing Agreement
16th Aug 20177:00 amRNSLaunch of breakthrough purification system
28th Jul 20172:57 pmRNSDirector leave of absence
27th Jun 20177:02 amRNSHalf-year Report
19th Jun 20173:00 pmRNSNotice of Results
25th May 20177:00 amRNSTrading Update and Notice of Results
2nd May 20177:00 amRNSTotal Voting Rights
26th Apr 201710:54 amRNSDirector Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.